A Study to Evaluate the Safety and Efficacy of COVID-19 Convalescent Plasma (CCP) Transfusion to Prevent COVID-19 in Adult Recipients Following Hematopoietic Stem Cell Transplantation
Clinical trial NCT05904067 · UNKNOWN
Trial details
- NCT number
- NCT05904067
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-10
- Primary completion
- 2024-01-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.